{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T09:15:39Z","timestamp":1740388539407,"version":"3.37.3"},"posted":{"date-parts":[[2024,8,11]]},"group-title":"In Review","reference-count":52,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:00:00Z","timestamp":1723334400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,6,25]]},"abstract":"<title>Abstract<\/title>\n        <p>Acylcarnitines (ACs) are involved in bioenergetics processes that may play a role in the pathophysiology of depression. Previous genomic evidence identified four ACs potentially linked to depression risk. We carried forward these ACs and tested the association of their circulating levels with Major Depressive Disorder (MDD) diagnosis, overall depression severity and specific symptom profiles. The sample from the Netherlands Study of Depression and Anxiety included participants with current (n\u2009=\u20091035) or remitted (n\u2009=\u2009739) MDD and healthy controls (n\u2009=\u2009800). Plasma levels of four ACs (short-chain: acetylcarnitine C2 and propionylcarnitine C3; medium-chain: octanoylcarnitine C8 and decanoylcarnitine C10) were measured. Overall depression severity as well as atypical\/energy-related (AES), anhedonic and melancholic symptom profiles were derived from the Inventory of Depressive Symptomatology. As compared to healthy controls, subjects with current or remitted MDD presented similarly lower mean C2 levels (Cohen\u2019s d\u2009=\u20090.2, p\u2009\u2264\u20091e-4). Higher overall depression severity was significantly associated with higher C3 levels (\u00df=0.06, SE\u2009=\u20090.02, p\u2009=\u20091.21e-3). No associations were found for C8 and C10. Focusing on symptom profiles, only higher AES scores were linked to lower C2 (\u00df=-0.05, SE\u2009=\u20090.02, p\u2009=\u20091.85e-2) and higher C3 (\u00df=0.08, SE\u2009=\u20090.02, p\u2009=\u20093.41e-5) levels. Results were confirmed in analyses pooling data with an additional internal replication sample from the same subjects measured at 6-year follow-up (totaling 4141 observations). Small alterations in levels of short-chain acylcarnitine levels were related to the presence and severity of depression, especially for symptoms reflecting altered energy homeostasis. Cellular metabolic dysfunctions may represent a key pathway in depression pathophysiology potentially accessible through AC metabolism.<\/p>","DOI":"10.21203\/rs.3.rs-4638158\/v1","type":"posted-content","created":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T12:05:33Z","timestamp":1723377933000},"source":"Crossref","is-referenced-by-count":0,"title":["Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3697-6617","authenticated-orcid":false,"given":"yuri","family":"milaneschi","sequence":"first","affiliation":[{"name":"Amsterdam UMC, Vrije Universiteit\/GGZ inGeest"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3333-6737","authenticated-orcid":false,"given":"Rick","family":"Jansen","sequence":"additional","affiliation":[{"name":"Amsterdam UMC location Vrije Universiteit Amsterdam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Schranner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabi","family":"Kastenm\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-0923","authenticated-orcid":false,"given":"Matthias","family":"Arnold","sequence":"additional","affiliation":[{"name":"Helmholtz Zentrum M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delfina","family":"Janiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9767-8752","authenticated-orcid":false,"given":"Gabriele","family":"Sani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3493-6029","authenticated-orcid":false,"given":"Sudeepa","family":"Bhattacharyya","sequence":"additional","affiliation":[{"name":"Arkansas State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siamak Mahmoudian","family":"Dehkordi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4653-0483","authenticated-orcid":false,"given":"Boadie","family":"Dunlop","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augustus","family":"Rush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7779-9672","authenticated-orcid":false,"given":"brenda","family":"penninx","sequence":"additional","affiliation":[{"name":"Amsterdam UMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rima","family":"Kaddurah-Daouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"GBD Results. Institute for Health Metrics and Evaluation, https:\/\/vizhub.healthdata.org\/gbd-results (accessed 20 October 2023)."},{"author":"Milaneschi Y","key":"ref2","doi-asserted-by":"publisher","unstructured":"Milaneschi Y, Lamers F, Berk M, et al. Depression Heterogeneity and Its Biological Underpinnings: Toward Immunometabolic Depression. Biological Psychiatry; 88. Epub ahead of print 2020. DOI: 10.1016\/j.biopsych.2020.01.014.","DOI":"10.1016\/j.biopsych.2020.01.014"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12916-015-0310-y","article-title":"The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders","volume":"13","author":"Morris G","year":"2015","unstructured":"Morris G, Berk M. The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med 2015; 13: 68.","journal-title":"BMC Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1073\/pnas.1321881111","article-title":"Mitochondria impact brain function and cognition","volume":"111","author":"Picard M","year":"2014","unstructured":"Picard M, McEwen BS. Mitochondria impact brain function and cognition. Proc Natl Acad Sci U S A 2014; 111: 7\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/nn.4086","article-title":"Mechanisms of stress in the brain","volume":"18","author":"McEwen BS","year":"2015","unstructured":"McEwen BS, Bowles NP, Gray JD, et al. Mechanisms of stress in the brain. Nat Neurosci 2015; 18: 1353\u20131363.","journal-title":"Nat Neurosci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3945\/jn.108.103754","article-title":"Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women","volume":"139","author":"Adams SH","year":"2009","unstructured":"Adams SH, Hoppel CL, Lok KH, et al. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J Nutr 2009; 139: 1073\u20131081.","journal-title":"J Nutr"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrendo.2015.129","article-title":"Acylcarnitines\u2013old actors auditioning for new roles in metabolic physiology","volume":"11","author":"McCoin CS","year":"2015","unstructured":"McCoin CS, Knotts TA, Adams SH. Acylcarnitines\u2013old actors auditioning for new roles in metabolic physiology. Nat Rev Endocrinol 2015; 11: 617\u2013625.","journal-title":"Nat Rev Endocrinol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.3945\/ajcn.116.130492","article-title":"Plasma acylcarnitines and risk of cardiovascular disease: effect of Mediterranean diet interventions","volume":"103","author":"Guasch-Ferr\u00e9 M","year":"2016","unstructured":"Guasch-Ferr\u00e9 M, Zheng Y, Ruiz-Canela M, et al. Plasma acylcarnitines and risk of cardiovascular disease: effect of Mediterranean diet interventions. Am J Clin Nutr 2016; 103: 1408\u20131416.","journal-title":"Am J Clin Nutr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"577856","DOI":"10.3389\/fphys.2020.577856","article-title":"Long-Chain Acylcarnitines and Cardiac Excitation-Contraction Coupling: Links to Arrhythmias","volume":"11","author":"Aitken-Buck HM","year":"2020","unstructured":"Aitken-Buck HM, Krause J, Zeller T, et al. Long-Chain Acylcarnitines and Cardiac Excitation-Contraction Coupling: Links to Arrhythmias. Front Physiol 2020; 11: 577856.","journal-title":"Front Physiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1124\/pharmrev.121.000408","article-title":"Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials","volume":"74","author":"Dambrova M","year":"2022","unstructured":"Dambrova M, Makrecka-Kuka M, Kuka J, et al. Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials. Pharmacol Rev 2022; 74: 506\u2013551.","journal-title":"Pharmacol Rev"},{"author":"Li S","key":"ref11","doi-asserted-by":"publisher","unstructured":"Li S, Gao D, Jiang Y. Function, detection and alteration of acylcarnitine metabolism in hepatocellular carcinoma. Metabolites; 9. Epub ahead of print 2019. DOI: 10.3390\/metabo9020036.","DOI":"10.3390\/metabo9020036"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0005-2760(86)90332-2","article-title":"Entry of acetyl-L-carnitine into biosynthetic pathways","volume":"876","author":"Farrell S","year":"1986","unstructured":"Farrell S, Vogel J, Bieber LL. Entry of acetyl-L-carnitine into biosynthetic pathways. Biochim Biophys Acta 1986; 876: 175\u2013177.","journal-title":"Biochim Biophys Acta"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jnutbio.2005.03.027","article-title":"Acetylcarnitine and cellular stress response: roles in nutritional redox homeostasis and regulation of longevity genes","volume":"17","author":"Calabrese V","year":"2006","unstructured":"Calabrese V, Giuffrida Stella AM, Calvani M, et al. Acetylcarnitine and cellular stress response: roles in nutritional redox homeostasis and regulation of longevity genes. J Nutr Biochem 2006; 17: 73\u201388.","journal-title":"J Nutr Biochem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/npp.2013.121","article-title":"Upregulation of mGlu2 receptors via NF-\u03baB p65 acetylation is involved in the Proneurogenic and antidepressant effects of acetyl-L-carnitine","volume":"38","author":"Cuccurazzu B","year":"2013","unstructured":"Cuccurazzu B, Bortolotto V, Valente MM, et al. Upregulation of mGlu2 receptors via NF-\u03baB p65 acetylation is involved in the Proneurogenic and antidepressant effects of acetyl-L-carnitine. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 2013; 38: 2220\u20132230.","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.mp.4000805","article-title":"Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer\u2019s disease and geriatric depression","volume":"5","author":"Pettegrew JW","year":"2000","unstructured":"Pettegrew JW, Levine J, McClure RJ. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer\u2019s disease and geriatric depression. Mol Psychiatry 2000; 5: 616\u2013632.","journal-title":"Mol Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.mam.2004.06.003","article-title":"Role of carnitine esters in brain neuropathology","volume":"25","author":"Virmani A","year":"2004","unstructured":"Virmani A, Binienda Z. Role of carnitine esters in brain neuropathology. Mol Aspects Med 2004; 25: 533\u2013549.","journal-title":"Mol Aspects Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13195-019-0551-7","article-title":"Systemic and central nervous system metabolic alterations in Alzheimer\u2019s disease","volume":"11","author":"Velpen V","year":"2019","unstructured":"van der Velpen V, Teav T, Gallart-Ayala H, et al. Systemic and central nervous system metabolic alterations in Alzheimer\u2019s disease. Alzheimers Res Ther 2019; 11: 93.","journal-title":"Alzheimers Res Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2019.10.014","article-title":"Brain and blood metabolome for Alzheimer\u2019s dementia: findings from a targeted metabolomics analysis","volume":"86","author":"Huo Z","year":"2020","unstructured":"Huo Z, Yu L, Yang J, et al. Brain and blood metabolome for Alzheimer\u2019s dementia: findings from a targeted metabolomics analysis. Neurobiol Aging 2020; 86: 123\u2013133.","journal-title":"Neurobiol Aging"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"7328","DOI":"10.1038\/s41598-017-06767-y","article-title":"Decreased long-chain acylcarnitines from insufficient \u03b2-oxidation as potential early diagnostic markers for Parkinson\u2019s disease","volume":"7","author":"Saiki S","year":"2017","unstructured":"Saiki S, Hatano T, Fujimaki M, et al. Decreased long-chain acylcarnitines from insufficient \u03b2-oxidation as potential early diagnostic markers for Parkinson\u2019s disease. Sci Rep 2017; 7: 7328.","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1007\/s12035-017-0845-3","article-title":"Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson\u2019s Disease","volume":"55","author":"Chang K-H","year":"2018","unstructured":"Chang K-H, Cheng M-L, Tang H-Y, et al. Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson\u2019s Disease. Mol Neurobiol 2018; 55: 6319\u20136328.","journal-title":"Mol Neurobiol"},{"key":"ref21","first-page":"1011","article-title":"Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson\u2019s Disease","volume":"10","author":"Molsberry S","year":"2020","unstructured":"Molsberry S, Bjornevik K, Hughes KC, et al. Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson\u2019s Disease. J Park Dis 2020; 10: 1011\u20131021.","journal-title":"J Park Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jad.2022.03.070","article-title":"Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression","volume":"307","author":"Milaneschi Y","year":"2022","unstructured":"Milaneschi Y, Arnold M, Kastenm\u00fcller G, et al. Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression. J Affect Disord 2022; 307: 254\u2013263.","journal-title":"J Affect Disord"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller AH","year":"2016","unstructured":"Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 2016; 16: 22\u201334.","journal-title":"Nat Rev Immunol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2021.03.026","article-title":"Cohort profile of the longitudinal Netherlands Study of Depression and Anxiety (NESDA) on etiology, course and consequences of depressive and anxiety disorders","volume":"287","author":"Penninx BWJH","unstructured":"Penninx BWJH, Eikelenboom M, Giltay EJ, et al. Cohort profile of the longitudinal Netherlands Study of Depression and Anxiety (NESDA) on etiology, course and consequences of depressive and anxiety disorders. J Affect Disord; 287. Epub ahead of print 2021. DOI: 10.1016\/j.jad.2021.03.026.","journal-title":"J Affect Disord"},{"author":"Wittchen HU","key":"ref25","doi-asserted-by":"publisher","unstructured":"Wittchen HU. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): A critical review. J Psychiatr Res; 28. Epub ahead of print 1994. DOI: 10.1016\/0022-3956(94)90036-1.","DOI":"10.1016\/0022-3956(94)90036-1"},{"author":"Rush AJ","key":"ref26","doi-asserted-by":"publisher","unstructured":"Rush AJ, Gullion CM, Basco MR, et al. The inventory of depressive symptomatology (IDS): Psychometric properties. Psychol Med; 26. Epub ahead of print 1996. DOI: 10.1017\/s0033291700035558.","DOI":"10.1017\/s0033291700035558"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.04.002","article-title":"Depression profilers and immuno-metabolic dysregulation: Longitudinal results from the NESDA study","volume":"88","author":"Lamers F","unstructured":"Lamers F, Milaneschi Y, Vinkers CH, et al. Depression profilers and immuno-metabolic dysregulation: Longitudinal results from the NESDA study. Brain Behav Immun; 88. Epub ahead of print 2020. DOI: 10.1016\/j.bbi.2020.04.002.","journal-title":"Brain Behav Immun"},{"author":"Felger JC","key":"ref28","doi-asserted-by":"publisher","unstructured":"Felger JC, Li Z, Haroon E, et al. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry; 21. Epub ahead of print 2016. DOI: 10.1038\/mp.2015.168.","DOI":"10.1038\/mp.2015.168"},{"key":"ref29","article-title":"The Metabolome-Wide Signature of Major Depressive Disorder","author":"Jansen R","year":"2023","unstructured":"Jansen R, Milaneschi Y, Schranner D, et al. The Metabolome-Wide Signature of Major Depressive Disorder. Res Sq 2023; rs.3.rs-3127544.","journal-title":"Res Sq"},{"author":"Craig CL","key":"ref30","doi-asserted-by":"publisher","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, et al. International physical activity questionnaire: 12-Country reliability and validity. Med Sci Sports Exerc; 35. Epub ahead of print 2003. DOI: 10.1249\/01.MSS.0000078924.61453.FB.","DOI":"10.1249\/01.MSS.0000078924.61453.FB"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41398-020-01097-6","article-title":"Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram\/escitalopram in major depression","volume":"11","author":"MahmoudianDehkordi S","year":"2021","unstructured":"MahmoudianDehkordi S, Ahmed AT, Bhattacharyya S, et al. Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram\/escitalopram in major depression. Transl Psychiatry 2021; 11: 153.","journal-title":"Transl Psychiatry"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41380-021-01201-2","article-title":"Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction","volume":"27","author":"Guan F","year":"2022","unstructured":"Guan F, Ni T, Zhu W, et al. Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction. Mol Psychiatry 2022; 27: 113\u2013126.","journal-title":"Mol Psychiatry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbi.2022.02.003","article-title":"Metabolomic and inflammatory signatures of symptom dimensions in major depression","volume":"102","author":"Brydges CR","year":"2022","unstructured":"Brydges CR, Bhattacharyya S, Dehkordi SM, et al. Metabolomic and inflammatory signatures of symptom dimensions in major depression. Brain Behav Immun 2022; 102: 42\u201352.","journal-title":"Brain Behav Immun"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02484-5","article-title":"Metabolomics signatures of depression: the role of symptom profiles","volume":"13","author":"Kluiver H","unstructured":"Kluiver H de, Jansen R, Penninx BWJH, et al. Metabolomics signatures of depression: the role of symptom profiles. Transl Psychiatry; 13. Epub ahead of print 2023. DOI: 10.1038\/s41398-023-02484-5.","journal-title":"Transl Psychiatry"},{"author":"Morris SE","key":"ref35","doi-asserted-by":"publisher","unstructured":"Morris SE, Sanislow CA, Pacheco J, et al. Revisiting the seven pillars of RDoC. BMC Med; 20. Epub ahead of print 2022. DOI: 10.1186\/s12916-022-02414-0.","DOI":"10.1186\/s12916-022-02414-0"},{"author":"Pizzagalli D","key":"ref36","doi-asserted-by":"publisher","unstructured":"Pizzagalli D. Depression, stress, and anhedonia: toward a synthesis and integrated model. Annu Rev Clin Psychol; 10. Epub ahead of print 2014. DOI: 10.1146\/annurev-clinpsy-050212-185606.","DOI":"10.1146\/annurev-clinpsy-050212-185606"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2021_294","article-title":"Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications","volume":"58","author":"Bekhbat M","unstructured":"Bekhbat M, Treadway M, Felger J. Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications. Curr Top Behav Neurosci; 58. Epub ahead of print 2022. DOI: 10.1007\/7854_2021_294.","journal-title":"Curr Top Behav Neurosci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/msb.2009.11","article-title":"High heritability of metabolomic profiles in families burdened with premature cardiovascular disease","volume":"5","author":"Shah SH","year":"2009","unstructured":"Shah SH, Hauser ER, Bain JR, et al. High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol 2009; 5: 258.","journal-title":"Mol Syst Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.cmet.2018.05.011","article-title":"Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States","volume":"27","author":"Mattson MP","year":"2018","unstructured":"Mattson MP, Arumugam TV. Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States. Cell Metab 2018; 27: 1176\u20131199.","journal-title":"Cell Metab"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1073\/pnas.1216100110","article-title":"L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors","volume":"110","author":"Nasca C","year":"2013","unstructured":"Nasca C, Xenos D, Barone Y, et al. L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. Proc Natl Acad Sci U S A 2013; 110: 4804\u20134809.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuroscience.2014.11.025","article-title":"Rapid-acting antidepressant-like effects of acetyl-l-carnitine mediated by PI3K\/AKT\/BDNF\/VGF signaling pathway in mice","volume":"285","author":"Wang W","year":"2015","unstructured":"Wang W, Lu Y, Xue Z, et al. Rapid-acting antidepressant-like effects of acetyl-l-carnitine mediated by PI3K\/AKT\/BDNF\/VGF signaling pathway in mice. Neuroscience 2015; 285: 281\u2013291.","journal-title":"Neuroscience"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/mp.2016.68","article-title":"Stress-induced structural plasticity of medial amygdala stellate neurons and rapid prevention by a candidate antidepressant","volume":"22","author":"Lau T","year":"2017","unstructured":"Lau T, Bigio B, Zelli D, et al. Stress-induced structural plasticity of medial amygdala stellate neurons and rapid prevention by a candidate antidepressant. Mol Psychiatry 2017; 22: 227\u2013234.","journal-title":"Mol Psychiatry"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"100080","DOI":"10.1016\/j.bbih.2020.100080","article-title":"Mitochondrial respiratory capacity modulates LPS-induced inflammatory signatures in human blood","volume":"5","author":"Karan KR","year":"2020","unstructured":"Karan KR, Trumpff C, McGill MA, et al. Mitochondrial respiratory capacity modulates LPS-induced inflammatory signatures in human blood. Brain Behav Immun - Health 2020; 5: 100080.","journal-title":"Brain Behav Immun - Health"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"103312","DOI":"10.1016\/j.isci.2021.103312","article-title":"Reduced mitochondrial respiration in T cells of patients with major depressive disorder","volume":"24","author":"Gamradt S","year":"2021","unstructured":"Gamradt S, Hasselmann H, Taenzer A, et al. Reduced mitochondrial respiration in T cells of patients with major depressive disorder. iScience 2021; 24: 103312.","journal-title":"iScience"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.phrs.2015.11.014","article-title":"Decreased acylcarnitine content improves insulin sensitivity in experimental mice models of insulin resistance","volume":"113","author":"Liepinsh E","year":"2016","unstructured":"Liepinsh E, Makrecka-Kuka M, Makarova E, et al. Decreased acylcarnitine content improves insulin sensitivity in experimental mice models of insulin resistance. Pharmacol Res 2016; 113: 788\u2013795.","journal-title":"Pharmacol Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.3390\/nu11102331","article-title":"The Association between Alcohol Consumption and Serum Metabolites and the Modifying Effect of Smoking","volume":"11","author":"Langenau J","year":"2019","unstructured":"Langenau J, Boeing H, Bergmann MM, et al. The Association between Alcohol Consumption and Serum Metabolites and the Modifying Effect of Smoking. Nutrients 2019; 11: 2331.","journal-title":"Nutrients"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/metabo12050370","article-title":"Metabolomics of Arterial Stiffness","volume":"12","author":"Paapstel K","year":"2022","unstructured":"Paapstel K, Kals J. Metabolomics of Arterial Stiffness. Metabolites 2022; 12: 370.","journal-title":"Metabolites"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/ajcn\/nqac252","article-title":"Gut microbiota and acylcarnitine metabolites connect the beneficial association between equol and adiposity in adults: a prospective cohort study","volume":"116","author":"Wu Y-Y","year":"2022","unstructured":"Wu Y-Y, Gou W, Yan Y, et al. Gut microbiota and acylcarnitine metabolites connect the beneficial association between equol and adiposity in adults: a prospective cohort study. Am J Clin Nutr 2022; 116: 1831\u20131841.","journal-title":"Am J Clin Nutr"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1073\/pnas.1801609115","article-title":"Acetyl-l-carnitine deficiency in patients with major depressive disorder","volume":"115","author":"Nasca C","year":"2018","unstructured":"Nasca C, Bigio B, Lee FS, et al. Acetyl-l-carnitine deficiency in patients with major depressive disorder. Proc Natl Acad Sci U S A 2018; 115: 8627\u20138632.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"853058","DOI":"10.3389\/fnut.2022.853058","article-title":"Carnitine and Depression","volume":"9","author":"Liu T","year":"2022","unstructured":"Liu T, Deng K, Xue Y, et al. Carnitine and Depression. Front Nutr 2022; 9: 853058.","journal-title":"Front Nutr"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/ijns9030048","article-title":"New Acylcarnitine Ratio as a Reliable Indicator of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency","volume":"9","author":"Baydakova GV","year":"2023","unstructured":"Baydakova GV, Tsygankova PG, Pechatnikova NL, et al. New Acylcarnitine Ratio as a Reliable Indicator of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency. Int J Neonatal Screen 2023; 9: 48.","journal-title":"Int J Neonatal Screen"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"871","DOI":"10.21037\/tp-22-468","article-title":"Increased acylcarnitine ratio indices in newborn screening for carnitine-acylcarnitine translocase deficiency shows increased sensitivity and reduced false-positivity","volume":"12","author":"Shi C","year":"2023","unstructured":"Shi C, Ao Z, Liu B, et al. Increased acylcarnitine ratio indices in newborn screening for carnitine-acylcarnitine translocase deficiency shows increased sensitivity and reduced false-positivity. Transl Pediatr 2023; 12: 871\u2013881.","journal-title":"Transl Pediatr"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4638158\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4638158\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T08:06:39Z","timestamp":1740384399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4638158\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,11]]},"references-count":52,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4638158\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41398-025-03274-x","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,8,11]]},"subtype":"preprint"}}